Sonjoy Laskar MD

Department of Medicine
Associate Professor

(404) 778-5544
slaskar@emory.edu

Overview

Dr. Laskar is an associate professor of medicine in the Division of Cardiology at Emory University. He received his MD degree from Emory University in 1996. He received his internal medicine and cardiology training at the University of Texas Southwestern in Dallas, Texas. He received additional training in advanced heart failure and heart transplantation at the University of Texas Southwestern. He joined the faculty in 2004.

Dr. Laskar is the medical director of the Emory Healthcare VAD Program. Dr. Laskar has demonstrated a true devotion to providing direct care to patients with heart failure, heart transplantation or ventricular assist devices, and teaching residents and fellows. Dr. Laskar also travels throughout Georgia and South Carolina providing education to physicians about treatment options available for patients with heart failure. Dr. Laskar is an active researcher in the areas of echocardiography and ventricular assist devices as destination therapy. Dr. Laskar is also board certified in Advanced Heart Failure and Transplant Cardiology.

Academic Appointment

Senior Physician, Emory University School of Medicine
Associate Professor of Medicine, Department of Medicine, Division of Cardiology, Emory University School of Medicine

Education

Degrees

MD from Emory University School of Medicine
BS from Clemson University

Research

Focus

Cardiac imaging in patients with heart failure and post heart transplant. Mechanical circulatory support for advanced heart failure

Publications

Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock.
Artif Organs Volume: 48 Page(s): 921 - 931
08/01/2024 Authors: Schurr JW; Ambrosi L; Fitzgerald J; Bermudez C; Genuardi MV; Brahier M; Elliot T; McGowan K; Zaaqoq A; Laskar S
Analysis Paralysis: Transition to HeartMate 3 Left Ventricular Assist Device Despite Multiple Complications from COVID-19
Volume: 41 Page(s): S223 - S223
04/01/2022 Authors: BhatiaPatel S; Patel P; Yoo B; Abdou M; Attia T; Daneshmand M; Dickert N; Jokhadar M; Laskar S; Morris A
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies.
Clin Transplant Volume: 36 Page(s): e14502
01/01/2022 Authors: Steinberg RS; Nayak A; Burke MA; Aldridge M; Raja Laskar S; Bhatt K; Sridharan L; Abdou M; Attia T; Smith A
The Stanford Integrated Psychosocial Assessment for Transplantation Score Predicts Frequency of Hospital Readmissions in Left Ventricular Assist Device Patients
Volume: 40 Page(s): S169 - S169
04/01/2021 Authors: Schwartz AM; Hu Y; Nayak A; Tannu M; Laskar SR; Gupta D; Vega JD; Morris AA
Outcomes with Impella in Cardiogenic Shock
Volume: 26 Page(s): S155 - S156
10/01/2020 Authors: Herve F; Tonleu A; Lyle M; Staloch D; Sridharan L; Bhatt K; Morris A; Burke M; Smith A; Attia T
Sex differences in eligibility for advanced heart failure therapies.
Clin Transplant Volume: 34 Page(s): e13839
05/01/2020 Authors: Steinberg RS; Nayak A; O'Connell C; Burford S; Pekarek A; Chesnut N; Cole RT; Gupta D; Laskar SR; Bhatt K
Outflow Graft Obstruction Causing Recurrent Heart Failure after Left Ventricular Assist Device Implantation.
Volume: 39 Page(s): S98
04/01/2020 Authors: Burke MA; Alexy T; Kamioka N; Shafi T; Turbyfield CT; Stowe J; Porter JA; Iturbe JM; Kim DW; Wittersheim KM
Stereotactic Body Radiation for Refractory Ventricular Tachycardia in Patients with Left Ventricular Assist Devices.
Volume: 39 Page(s): S349
04/01/2020 Authors: Lyle M; Lloyd M; Higgins K; Sridharan L; Bhatt K; Laskar S; Gupta D; Smith A; Vega D; Tamer A
Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience.
Clin Transplant Volume: 34 Page(s): e13816
03/01/2020 Authors: Nayak A; Dong T; Ko Y-A; Chesnut N; Pekarek A; Cole RT; Bhatt K; Gupta D; Burke MA; Laskar SR
SIPAT B Score Predicts Mortality in Both BTT and DT Male LVAD Patients
Volume: 25 Page(s): S170 - S170
08/01/2019 Authors: Dong T; Doshi N; Steinberg R; Nayak A; O'Connell C; Howser J; Laskar S; Smith A; Vega D; Morris A
Sensitization in LVAD Recipients with and without Transfusions
Volume: 38 Page(s): S453 - S453
04/01/2019 Authors: Dong T; Demoss B; Roy R; Smith A; Vega J; Laskar S; Bhatt K; Gupta D; Morris A; Cole RT
Validating Patient Prioritization in the 2018 Revised UNOS Heart Allocation System: A Single Center Experience
Volume: 38 Page(s): S133 - S133
04/01/2019 Authors: Nayak A; Ko Y; Chesnut N; Pekarek A; Cole RT; Bhatt K; Gupta D; Burke M; Laskar SR; Attia TS
Effects of Induction on the Risk of Post-Transplant De Novo DSA
Volume: 38 Page(s): S387 - S388
04/01/2019 Authors: Cole RT; Minto J; Flattery M; Parikh A; Dong T; Roy R; Bogar L; Morris A; Vega J; Gupta D
Risk of dnDSA with Various MCS Devices as Bridge-to-Transplant
Volume: 38 Page(s): S91 - S91
04/01/2019 Authors: Cole RT; Flattery M; Minto J; Parikh A; Dong T; Roy R; Bogar L; Smith A; Vega J; Morris A
SEX DIFFERENCES IN ELIGIBILITY FOR ADVANCED HEART FAILURE THERAPIES
Volume: 73 Page(s): 933 - 933
03/12/2019 Authors: Steinberg R; Nayak A; Cole R; Gupta D; Laskar S; Bhatt K; Burke M; Smith A; Vega J; Morris AA
Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
Int J Cardiol Volume: 276 Page(s): 185 - 190
02/01/2019 Authors: Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
Decisional regret in left ventricular assist device patient-caregiver dyads.
Heart Lung Volume: 48 Page(s): 400 - 404
01/01/2019 Authors: Stahl EP; Dickert NW; Cole RT; Laskar SR; Morris AA; Smith AL; Vega JD; Gupta D
Preemptive vs. Upfront CMV Prophylaxis Strategies and Risk of Non-CMV Herpesvirus Infections in Intermediate Risk Heart Transplant Recipients
Volume: 37 Page(s): S178 - S178
04/01/2018 Authors: Eng N; Chen C; Aldridge M; Osborne A; Vega J; Mitchell H; Smith A; Hurtik M; Morris A; Gupta D
Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies
Volume: 37 Page(s): S150 - S151
04/01/2018 Authors: Cole RT; Minto J; Bogar L; Miller H; Morris A; Gupta D; Smith A; Vega J; Laskar S; Bhatt K
Preemptive vs. Upfront CMV Prophylaxis Strategies and the Risk of Treated CMV in Intermediate Risk Heart Transplant Recipients
Volume: 37 Page(s): S355 - S355
04/01/2018 Authors: Chen C; Eng N; Aldridge M; Itchell HM; Osborne A; Morris A; Hurtik M; Gupta D; Bhatt K; Laskar S
Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively
Volume: 37 Page(s): S423 - S424
04/01/2018 Authors: Mahoney I; Young A; Shekiladze N; Morris A; Gupta D; Bhatt K; Laskar S; Smith A; Vega J; Cole RT
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.
J Heart Lung Transplant Volume: 37 Page(s): 503 - 512
04/01/2018 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Yin M; Shekiladze N; Young A; Grant A; Mahoney I; Laskar SR
IMPACT OF INSURANCE TYPE ON ELIGIBILITY FOR ADVANCED HEART FAILURE THERAPIES AND SURVIVAL
Volume: 71 Page(s): 671 - 671
03/10/2018 Authors: Hutcheson S; Patzer R; Laskar S; Smith A; Vega J; Morris A
Utility of Neurohormonal Blockade in Patients Receiving Milrinone as Bridge to Transplant
Volume: 23 Page(s): S36 - S37
08/01/2017 Authors: Lee S; Lebeis T; Morris A; Gupta D; Bhatt K; Laskar SR; Nguyen D; Smith A; Vega JD; Alexy T
Continuation of Beta Blocker Therapy Reduces Hospitalizations in Patients Treated with Milrinone as a Bridge to Transplant
Volume: 23 Page(s): S19 - S20
08/01/2017 Authors: Lebeis T; Lee S; Alexy T; Morris A; Gupta D; Bhatt K; Laskar SR; Smith A; Duc N; Vega JD
Percutaneous Repair of Continuous Flow Left Ventricular Assist Device (CF-LVAD) Outflow Graft Stenosis: Single Center Experience
Volume: 23 Page(s): S127 - S127
08/01/2017 Authors: Alexy T; Kamioka N; Iturbe JM; Vega DJ; Cole RT; Laskar SR; Babaliaros V; Burke MA
Racial Differences in the Development of De Novo DSA andTreated AMR Following Heart Transplantation
Volume: 36 Page(s): S200 - S200
04/01/2017 Authors: Cole RT; Gandhi J; Yin M; Laskar SR; Gupta D; Nguyen D; Smith A; Vega JD; Morris A
ELEVATED PRE-OPERATIVE CREATININE IS A RISK FACTOR FOR LATE-ONSET RIGHT HEART FAILURE AFTER LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION
Volume: 36 Page(s): S422 - S423
04/01/2017 Authors: Kim J; Pekarek A; Nguyen D; Vega J; Cole R; Morris AA; Smith A; Laskar S; Gupta D
Late-Onset Right Heart Failure After Left Ventricular Assist Device Implantation Is Associated with Poor Prognosis
Volume: 36 Page(s): S427 - S428
04/01/2017 Authors: Kim J; Pekarek A; Nguyen D; Vega J; Cole R; Morris A; Smith A; Laskar S; Gupta D
Increased Risk of Bleeding Associated with VKORC1 Gene Polymorphism in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVAD)
Volume: 36 Page(s): S174 - S175
04/01/2017 Authors: Alexy T; Schultz WM; Cole RT; Laskar SR; Pekarek A; Duncan A; Smith AL; Vega DJ; Nguyen DQ; Gupta D
Markers of Coagulation and Hemostasis Activation in Left Ventricular Assist Device Recipients
Volume: 36 Page(s): S249 - S249
04/01/2017 Authors: Moorman AF; Hurtik ML; Pekarek A; Laskar S; Gupta D
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.
Volume: 31
04/01/2017 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Morris A; McCue A; Yin M; Laskar SR; Book W; Jokhadar M
RECURRENT ATRIAL MYXOMAS OF CARNEY COMPLEX: PLEADING THE FIFTH
Volume: 69 Page(s): 2214 - 2214
03/21/2017 Authors: Carlisle A; Jokhadar M; Laskar S
Do the Reasons That Patients are Ineligible for Advanced Heart Failure Therapies Vary According to Insurance Type
Volume: 22 Page(s): S11 - S12
08/01/2016 Authors: Morris AA; Schultz W; Kelkar A; Halladay C; Gupta D; Cole RT; Duc N; Laskar SR; Vega JD; Smith A
SIPAT Scale May be Valuable in Psychosocial Assessment of LVAD Candidates
Volume: 22 Page(s): S79 - S79
08/01/2016 Authors: Tsarova K; Pekarek A; Wittersheim K; Burford S; Halladay C; Smith A; Morris A; Cole R; Laskar SR
Elevated Urinary 11-Dehydrothromboxane B2 Is Associated with Increased Bleeding Risk in Left Ventricular Assist Device Patients.
Volume: 16 Page(s): 291 - 291
06/01/2016 Authors: Schultz W; Pekarek A; Cole R; Duncan A; Laskar S; Smith A; Nguyen D; Vega J; Gupta D
Predictors of Out-of-Therapeutic-Range INR during Support with Continuous-Flow Left Ventricular Assist Device
Volume: 35 Page(s): S84 - S85
04/01/2016 Authors: Yin M; Schultz W; Ko Y; Cole RT; Gupta D; Laskar S; Smith A; Vega D; Nguyen D; Pekarek A
Warfarin, Rifampin, and LVADs-OH MY: Effect of Rifampin on INR and Time in the Therapeutic Range in Patients with a Left Ventricular Assist Device
Volume: 35 Page(s): S418 - S418
04/01/2016 Authors: Mangum JE; Hurtik ML; Pekarek A; Laskar SR
ABO Blood Group and Bleeding Post-LVAD
Volume: 35 Page(s): S253 - S253
04/01/2016 Authors: Cole RT; Gupta D; Lee J; Gandhi J; Lambert C; Garcia-Bengochea Y; Sandesara P; Yin M; Smith A; Laskar S
Elevated Levels of 11-dehydrothromboxane B2 in Urine Is Associated with an Increased Risk of Bleeding in Patients Supported with a Continuous Flow-Left Ventricular Assist Device
Volume: 35 Page(s): S249 - S249
04/01/2016 Authors: Gupta D; Pekarek A; Cole R; Nguyen D; Laskar SR; Smith AL; Wittersheim K; Vega JD
Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device.
Volume: 34 Page(s): 1570 - 1577
12/01/2015 Authors: Morris AA; Pekarek A; Wittersheim K; Cole RT; Gupta D; Nguyen D; Laskar SR; Butler J; Smith A; Vega JD
Mortality in Status 2 Patients Listed for Heart Transplantation in the United States: Will Understanding Mode of Death Help Justify Implantation of Left Ventricular Assist Devices Into Less Sick Patients?
Volume: 21 Page(s): S3 - S3
08/01/2015 Authors: Morris AA; Kalogeropoulos A; Kellcar A; Cole RT; Gupta D; Duc N; Laskar SR; Smith A; Vega D
Improved Outcomes for Women on the Heart Transplant Wait List in the Modern Era.
J Card Fail Volume: 21 Page(s): 555 - 560
07/01/2015 Authors: Morris AA; Cole RT; Laskar SR; Kalogeropoulos A; Vega JD; Smith A; Butler J
Race and ethnic differences in the epidemiology and risk factors for graft failure after heart transplantation.
J Heart Lung Transplant Volume: 34 Page(s): 825 - 831
06/01/2015 Authors: Morris AA; Kalogeropoulos AP; Zhao L; Owen M; Raja Laskar S; David Vega J; Smith A; Butler J
Impact of Insurance Status on LVAD Utilization and Health Outcomes for Patients Listed for Heart Transplantation
Volume: 34 Page(s): S123 - S123
04/01/2015 Authors: Morris AA; Kelkar A; Ko Y; Laskar SR; Smith AL; Vega JD
Low Prevalence of Left Ventricular Thrombus in Patients Undergoing Ventricular Assist Device Evaluation
Volume: 20 Page(s): S85 - S86
08/01/2014 Authors: Kay J; Pekarek A; Wittersheim K; Cole RT; Laskar SR; Due N; Vega JD; Sims DB
Routine Screening for AMR By C4d Immunohistochemical Staining Is of Low Clinical Utility and Associated With High False-Positive Rates: A Single Center, 2 Year Analysis of 1518 Biopsies
Volume: 98 Page(s): 57 - 58
07/15/2014 Authors: Cole R; Lambert C; Lewis W; Jokhadar M; Smith A; Laskar S; Book W; Butler J; Gupta D
Routine Screening for AMR By C4d Immunohistochemical Staining Is of Low Clinical Utility and Associated With High False-Positive Rates: A Single Center, 2 Year Analysis of 1518 Biopsies
Volume: 14 Page(s): 57 - 58
06/01/2014 Authors: Cole R; Lambert C; Lewis W; Jokhadar M; Smith A; Laskar S; Book W; Butler J; Gupta D
Race/Ethnic Differences in the Epidemiology of Graft Failure in a Contemporary Cohort
Volume: 33 Page(s): S90 - S90
04/01/2014 Authors: Morris AA; Kalogeropoulos A; Kransdorf E; Owen M; Cole RT; Brown J; Gupta D; Laskar SR; Smith A; Butler J
Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010.
Circ Heart Fail Volume: 7 Page(s): 28 - 34
01/01/2014 Authors: See I; Shehab N; Kegler SR; Laskar SR; Budnitz DS
Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
Volume: 62 Page(s): 2308 - 2315
12/17/2013 Authors: Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J
Poor Handgrip Strength and Outcomes in Heart Failure. The Atlanta Cardiomyopathy Consortium
Volume: 128
11/26/2013 Authors: Deka A; Li S; Marti CN; Snell G; Caltabiano N; Cole R; Gupta D; Laskar S; Smith AL; Butler J
Progression of Pulmonary Artery Systolic Pressures by Echocardiography among Ambulatory Patients without Pulmonary Hypertension at Baseline
Volume: 19 Page(s): S10 - S11
08/01/2013 Authors: Siwamogsatham S; Souvaliotis N; Papadimitriou L; Li S; Deka A; Marti C; Gupta D; Cole R; Laskar S; Smith AL
Score-Based Versus Clinical Evaluation of Heart Failure Severity among Patients Listed for Heart Transplantation
Volume: 19 Page(s): S21 - S21
08/01/2013 Authors: Deka A; Li S; Papadimitriou L; Siwamogsatham S; Marti C; Gupta D; Cole R; Smith AL; Laskar S; Kalogeropoulos A
Anxiety Symptoms, Major Clinical Events, and Healthcare Resource Utilization in Outpatients with Heart Failure in the Atlanta Cardiomyopathy Consortium (TACC) Study
Volume: 19 Page(s): S79 - S79
08/01/2013 Authors: Deka A; Li S; Papadimitriou L; Marti C; Gupta D; Cole R; Laskar S; Smith AL; Butler J; Kalogeropoulos A
Clinical Scores and Echocardiography for Right Ventricular Failure Risk Prediction after Implantation of Continuous-Flow Left Ventricular Assist Devices
Volume: 32 Page(s): S273 - S273
04/01/2013 Authors: Kalogeropoulos AP; Siwamogsatham S; Weinberger JF; Kelkar AA; Georgiopoulou VV; Pekarek A; Wittersheim KM; Gupta D; Cole RT; Laskar SR
Alterations in Flow and Shear Stress in the Thoracic Aorta with a Continuous-Flow Left Ventricular Assist Device
Volume: 31 Page(s): S44 - S44
04/01/2012 Authors: Gupta D; Piccinelli M; Passerini T; Veneziani A; Brewster L; Laskar SR; Nguyen DQ; Vega JD; Taylor WR
Exercise Capacity and Risk for Heart Failure in Older Adults. The Health, Aging, and Body Composition Study
CIRCULATION Volume: 124
11/22/2011 Authors: Georgiopoulou VV; Kalogeropoulos AP; Marti CN; Laskar SR; Smith AL; Bibbins-Domingo K; Newman AB; Harris T; Kritchevsky SB; Butler J
Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.
Int J Cardiol Volume: 151 Page(s): 237 - 239
09/01/2011 Authors: Bhalla V; Georgiopoulou VV; Azeem AA; Marti CN; Cole RT; Laskar SR; De Staercke C; Hooper WC; Smith AL; Kalogeropoulos AP
Cytomegalovirus prostatitis in a heart transplant recipient.
Am J Transplant Volume: 11 Page(s): 1330 - 1333
06/01/2011 Authors: Rouphael NG; Laskar SR; Smith A; Lyon GM
ADHERENCE, PREDICTORS OF ADHERENCE AND OUTCOMES ASSOCIATED WITH SELF-CARE RECOMMENDATIONS AMONG HEART FAILURE PATIENTS
Volume: 57 Page(s): E388 - E388
04/05/2011 Authors: Norton C; Georgiopoulou V; Kalogeropoulos A; Fike L; Giamouzis G; Laskar S; Cole R; Smith A; Tang WWH; Dunbar S
Patient perception versus medical record entry of health-related conditions among patients with heart failure.
Am J Cardiol Volume: 107 Page(s): 569 - 572
02/15/2011 Authors: Malik AS; Giamouzis G; Georgiopoulou VV; Fike LV; Kalogeropoulos AP; Norton CR; Sorescu D; Azim S; Laskar SR; Smith AL
Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions.
J Card Fail Volume: 17 Page(s): 54 - 75
01/01/2011 Authors: Giamouzis G; Kalogeropoulos A; Georgiopoulou V; Laskar S; Smith AL; Dunbar S; Triposkiadis F; Butler J
Increased Levels of Tissue Inhibitor of Metalloproteinase 1 Are Independently Associated with Adverse Outcomes in Outpatients with Heart Failure
CIRCULATION Volume: 122
11/23/2010 Authors: Georgiopoulou V; Kalogeropoulos A; De Staercke C; Fike L; Giamouzis G; Bhalla V; Malik A; Laskar SR; Smith AL; Hooper WC
Health Literacy in Outpatients with Heart Failure: Determinants and Association with Outcomes
CIRCULATION Volume: 122
11/23/2010 Authors: Georgiopoulou VV; Kalogeropoulos AP; Bhatt K; Kiani J; Fike L; Giamouzis G; Norton CR; Chowdhury MR; Laskar SR; Smith AL
Health Literacy, Self-Reported Education and Outcomes among Heart Failure Outpatients
Volume: 16 Page(s): S108 - S108
08/01/2010 Authors: Georgiopoulou VV; Kalogeropoulos AP; Gupta C; Giamouzis G; Norton CR; Bhatt K; Laskar S; Smith AL; Dunbar S; Butler J
Distribution. Treatment, and Health Record Documentation of Depression Symptoms In Heart Failure Outpatients
Volume: 16 Page(s): S111 - S111
08/01/2010 Authors: Kalogeropoulos AP; Georgiopoulou VV; Fike L; Giamouzis G; Bhatt K; Gupta C; Norton CR; Chowdhury M; Malik A; Laskar S
Patients' Reporting Versus Electronic Health Record Documentation of Comorbidities among Heart Failure Patients
Volume: 16 Page(s): S104 - S104
08/01/2010 Authors: Malik A; Fike L; Bhatt K; Norton CR; Giamouzis G; Gupta C; Kalogeropoulos AP; Georgiopouiou VV; Laskar S; Smith AL
Increased Levels of Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Are Independently Associated with Adverse Outcomes in Outpatients with Heart Failure
Volume: 16 Page(s): S32 - S33
08/01/2010 Authors: Georgiopoulou VV; Kalogeropoulos AP; Giamouzis G; Fike L; Bhatt K; Norton CR; Chowdhury MR; Malik A; Laskar S; Smith AL
Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.
Am J Cardiol Volume: 105 Page(s): 1353 - 1355
05/01/2010 Authors: Methvin A; Georgiopoulou VV; Kalogeropoulos AP; Malik A; Anarado P; Chowdhury M; Hussain I; Book WM; Laskar SR; Vega JD
Cardiac Index, Peak Exercise Oxygen Consumption, and Listing Priority for Cardiac Transplantation
Volume: 29 Page(s): S111 - S111
02/01/2010 Authors: Methvin AB; Georgiopoulou VV; Kalogeropoulos AP; Malik A; Anarado A; Chowdhury M; Hussain I; Book WM; Laskar SR; Vega JD
Echocardiography and risk prediction in advanced heart failure: incremental value over clinical markers.
J Card Fail Volume: 15 Page(s): 586 - 592
09/01/2009 Authors: Agha SA; Kalogeropoulos AP; Shih J; Georgiopoulou VV; Giamouzis G; Anarado P; Mangalat D; Hussain I; Book W; Laskar S
Renal function and outcomes in heart failure: admission values and in-hospital variations that most optimally define short and intermediate term mortality
EUROPEAN HEART JOURNAL Volume: 30 Page(s): 711 - 712
09/01/2009 Authors: Giamouzis G; Kalogeropoulos AP; Georgiopoulou VV; Agha SA; Bhatt D; Rashad MA; Laskar SR; Smith AL; Triposkiadis F; Butler J
Hemodynamic Correlates of Outcomes in Patients Hospitalized for Heart Failure
Volume: 15 Page(s): S98 - S99
08/01/2009 Authors: Hussain I; Anarado P; Kalogeropoulos AP; Chowdhury M; Georgiopoulou VV; Methvin A; Bhalla V; Mangalat D; Shih J; Agha SA
Hemodynamic Parameters and Renal Function in Patients Hospitalized for Heart Failure
Volume: 15 Page(s): S95 - S95
08/01/2009 Authors: Chowdhury M; Anarado P; Hussain I; Methvin A; Kalogeropoulos AP; Georgiopoulou VV; Bhalla V; Mangalat D; Shih J; Agha SA
Cardiac Index, Maximal Oxygen Consumption, and Outcomes in Patients with Advanced Heart Failure
Volume: 15 Page(s): S95 - S95
08/01/2009 Authors: Methvin A; Anarado P; Chowdhury M; Hussain I; Kalogcropoulos AP; Georgiopoulou VV; Bhalla V; Mangalat D; Shih J; Agha SA
Predicting Risk among Patients Listed for Heart Transplantation: Is It the Same as a General Heart Failure Population?
Volume: 15 Page(s): S102 - S102
08/01/2009 Authors: Georgiopoulou VV; Kalogeropoulos AP; Altaf A; Arif N; Anarado P; Kella D; Mansoor M; Giamouzis G; Agha SA; Book W
Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy.
Circ Heart Fail Volume: 2 Page(s): 90 - 97
03/01/2009 Authors: Georgiopoulou VV; Kalogeropoulos AP; Giamouzis G; Agha SA; Rashad MA; Waheed S; Laskar S; Smith AL; Butler J
Incremental value of renal function in risk prediction with the Seattle Heart Failure Model.
Am Heart J Volume: 157 Page(s): 299 - 305
02/01/2009 Authors: Giamouzis G; Kalogeropoulos AP; Georgiopoulou VV; Agha SA; Rashad MA; Laskar SR; Smith AL; Butler J
Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
J Am Coll Cardiol Volume: 53 Page(s): 334 - 342
01/27/2009 Authors: Kalogeropoulos AP; Georgiopoulou VV; Giamouzis G; Smith AL; Agha SA; Waheed S; Laskar S; Puskas J; Dunbar S; Vega D
Rapid onset and resolution of cardiogenic shock in a patient with pheochromocytoma.
Congest Heart Fail Volume: 15 Page(s): 151 - 153
01/01/2009 Authors: Shih JA; Williams BR; Merlino J; Butler J; Smith A; Book W; Laskar S
Atrial fibrillation and heart failure.
Congest Heart Fail Volume: 15 Page(s): 24 - 30
01/01/2009 Authors: Larned JM; Raja Laskar S
Digoxin and Outcomes in Patients with Advanced Heart Failure on Contemporary Optimal Treatment
Volume: 118 Page(s): S1027 - S1027
10/28/2008 Authors: Agha SA; Georglopoulou VV; Kalogeropoulos AP; Giamouzis G; Waheed S; Irfan AB; Rashad MA; Bhatt DV; Laskar S; Smith AL
Discriminative properties of the Seattle heart failure model in patients with advanced heart failure: is there a role for markers of renal function?
EUROPEAN HEART JOURNAL Volume: 29 Page(s): 177 - 177
08/01/2008 Authors: Giamouzis G; Kalogeropoulos A; Georgiopoulou V; Agha SA; Rashad MA; Laskar SR; Vega D; Wilson PW; Smith AL; Butler J
Racial variations in outcomes with diuretics in advanced heart failure
Volume: 14 Page(s): S89 - S89
08/01/2008 Authors: Agha SA; Giamotzis G; Kalogerpoulos A; Georgiopoulou V; Rashad MA; Dunhar S; Laskar S; Smith AL; Butler J
The role of renal function markers on the discriminative properties of the Seattle Heart Failure Model in patients with advanced heart failure
Volume: 14 Page(s): S82 - S82
08/01/2008 Authors: Giamouzis G; Agha SA; Georgiopoulou V; Kalogeropoulos A; Laskar S; Smith AL; Dunbar S; Butler J
Digoxin is an independent predictor of outcomes in contemporary advanced heart failure patients in addition to the Seattle Heart Failure Model
Volume: 14 Page(s): S96 - S96
08/01/2008 Authors: Agha SA; Georgiopoulou V; Giamouzis G; Kalogeropoulos A; Rashad MA; Waheed S; Bhatt DD; Laskar SR; Smith AL; Butler J
Digoxin and outcomes in patients with advanced heart failure and contemporary optimal treatment
Volume: 14 Page(s): S97 - S97
08/01/2008 Authors: Georgiopoulou V; Agha SA; Kalogeropoulos A; Giamouzis G; Bhatt DD; Waheed S; Laskar SR; Smith AL; Butler J
Utility of the Seattle Heart Failure model in medically treated patients with advanced heart failure
Volume: 27 Page(s): S182 - S183
02/01/2008 Authors: Larned J; Georgiopoulou V; Kalogeropoulos A; Giamouzis G; Anarado P; Waheed S; Bavikati V; Vega JD; Book W; Laskar S
Utility of the seattle heart failure model in patients with advanced heart failure treated with implantable cardioverter defibrillators and/or biventricular pacemakers
Volume: 27 Page(s): S126 - S127
02/01/2008 Authors: D'Amico C; Georgiopoulou V; Kalogeropoulos A; Giamouzis G; Anarado P; Larned J; Waheed S; Book W; Bavikati V; Laskar S
Diminished pre-operative creatinine clearance is not a marker for post-operative renal failure or mortality in heart transplant recipients
JOURNAL OF HEART AND LUNG TRANSPLANTATION Volume: 25 Page(s): S137 - S138
02/01/2006 Authors: Reddy VS; Mykytenko J; Smith A; Holl B; Book W; Laskar SR; D'Amico C; Vega JD
Novel therapies for heart failure: vasopressin and selective aldosterone antagonists.
Congest Heart Fail Volume: 11 Page(s): 21 - 29
01/01/2005 Authors: Kamath SA; Laskar SR; Yancy CW
Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
Neurology Volume: 63 Page(s): 301 - 304
07/27/2004 Authors: Baseman DG; O'Suilleabhain PE; Reimold SC; Laskar SR; Baseman JG; Dewey RB
The use of beta-adrenergic receptor antagonists in the treatment of African Americans with heart failure.
Congest Heart Fail Volume: 10 Page(s): 34 - 37
01/01/2004 Authors: Yancy CW; Laskar S; Eichhorn E
The prognostic significance of renal dysfunction in patients with chronic systolic heart failure.
Curr Cardiol Rep Volume: 5 Page(s): 205 - 210
05/01/2003 Authors: Laskar SR; Dries DL

Directory section navigation

Profile